• No results found

Original Article F68- cis -curcumin inhibits proliferation of DU-145 hormone-independent prostate cancer cells via downregulating PI3K/AKT signaling pathways

N/A
N/A
Protected

Academic year: 2020

Share "Original Article F68- cis -curcumin inhibits proliferation of DU-145 hormone-independent prostate cancer cells via downregulating PI3K/AKT signaling pathways"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1. Effects of F68-cis-Cur on DU145 cell viability and cell colony formation ability
Figure 2. Effects of F68-cis-Cur on the induction of cell cycle arrest in DU145 cells
Figure 3. F68-cis-Cur induced apopto-sis in DU145 cells and its growth in-
Figure 4. F68-cis-Cur suppressed activation of PI3K/AKT signaling pathways. (A and B) Expression of poly(ADP) ribose polymerase (PARP), cleaved PARP, Bax, B cell lymphoma-2, caspase-3, and components of the PI3K/AKT signaling pathways were analyzed by West
+2

References

Related documents

There is a compelling need to revise the MDR-TB diagnostic and treatment protocol with special emphasis on patients with previous TB treatment, history of contact, hos-

EIA: Environmental impact assessment; HIA: Health impact assessment; HIV: Human immunodeficiency virus; HRIA: Human rights impact assessment; ILO: International Labour

Use of safety helmet can decrease the risk of death and fatal injuries from a motorcycle crash (Hefny et al., 2012).It‟s a dire need to increase the use of helmet among

Objective 3b: To assess whether kidney transplant recipients have a higher incidence of non-vertebral fractures compared to the following age-, sex-, and cohort entry date

Weekly paclitaxel plus bevacizumab versus docetaxel as second or third-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC): results from the phase III

The prevalence of ESCC in subjects with esophageal achalasia was 26 cases in 1,000, with an increase in absolute risk of squamous cell carcinoma of 308.1 cases per 1,00,000

Assessment of Adalimumab Safety and Efficacy Studied as Induction Therapy in Crohn’s Disease) trial, reported by Hanauer et al, demonstrated that adalimumab was more effec-

Exercise endogenous urinary inosine, hypoxanthine, uric acid and total purine excretion after (A) 2 hours, and (B) 24 hours, of recovery from a 30s sprint bout. before and after